# Tirzepatide Trial Expands to Adolescents With Obesity > JAMA reports a new randomized trial testing tirzepatide in adolescents with obesity under the SURMOUNT program name. - URL: https://www.lifeconverted.com/learn/tirzepatide-trial-expands-to-adolescents-with-obesity - Category: Research News - Author: Priya Raman, Biochemistry Writer - Published: 2026-11-16 - Reading time: 1 min - Keywords: Tirzepatide Trial Expands to Adolescents With Obesity --- A newly indexed JAMA report, titled "Tirzepatide in Adolescents With Obesity: The SURMOUNT ADOLESCENTS Randomized Clinical Trial," according to [the PubMed listing](https://pubmed.ncbi.nlm.nih.gov/43035096/), extends the SURMOUNT research program, which has previously focused on adult weight management, into a younger population. [Tirzepatide](/peptides/tirzepatide) is a dual GIP and GLP-1 receptor agonist studied across multiple SURMOUNT trials for weight related outcomes. This entry marks it as a randomized clinical trial, the strongest tier of human research design, meaning participants were assigned by chance to receive the active compound or a comparison arm so that researchers can better isolate its effects from placebo response or natural variation. The PubMed record currently available does not include the abstract or detailed results, so we cannot report effect sizes, safety findings, or conclusions here. Readers should treat this as a signal that pediatric obesity research involving tirzepatide is actively progressing through peer reviewed clinical trial channels, rather than as confirmation of any specific outcome. As with all SURMOUNT work, trial results in adolescents would need separate regulatory review before informing any approved use in that age group. We will follow up once the full study details are accessible. *This article is for education only. It is not medical advice. Compounds discussed here are sold for research purposes. Talk to a licensed clinician before making health decisions.* ## Sources - JAMA, 2026, via PubMed: https://pubmed.ncbi.nlm.nih.gov/43035096/ --- Published by LifeConverted, https://www.lifeconverted.com/learn/tirzepatide-trial-expands-to-adolescents-with-obesity